Park Ha Biological Technology Co., Ltd. Ordinary Shares
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Xiaoqiu Zhang
- Full Time Employees
- 41
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- 901 & 901-2 Wuxi JS People's Republic of China 214000
- IPO Date
- Dec 27, 2024
- CIK
- 0001986247
- Website
- parkha.cn
- Similar Companies
- Business
- Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) develops and sells private-label skincare products under its proprietary Park Ha brand in China; operates in the Product Sales and Franchise Service segments; and provides complementary after-sales beauty services including light beauty experiences in directly operated and franchise stores. The company offers nearly 128 skincare products across 14 series covering basic skin physical protection, exfoliation, sebum film repair, surface microecological balance, and anti-aging categories; star products include the Little Blue Injection Serum, featuring multiple peptide active substances for hydration, moisturizing, brightening, and firming, as well as freeze-dried powders with fibronectin and cherry blossom extract for firmer, tender skin; additional offerings comprise Park Ha Amino Acid Cleansing Foam and other formulations developed through in-house research at its Jiangsu Park Ha Biological Technology Co., Ltd. subsidiary in collaboration with institutions like Jiangnan University, with production outsourced to licensed third-party manufacturers under strict ingredient and quality controls. Founded in 2016 and headquartered at 901 & 901-2, Building C, Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China, the company conducts operations through Chinese subsidiaries Jiangsu Park Ha Biological Technology (R&D and direct stores), Shanghai Park Ha Industrial Development (franchisee training), and Wuxi Xinzhan Enterprise Management Consulting (marketing and franchising); as of April 30, 2024, it maintains two directly operated stores and 43 franchisees, with 41 under the Park Ha name and two under Geni. In December 2024, Park Ha completed a $4.8 million initial public offering on Nasdaq Capital Market by selling 1,200,000 ordinary shares at $4.00 each, granting underwriters a 45-day option for 180,000 additional shares, with net proceeds allocated to expanding directly owned stores in China, acquiring product patents for proprietary development, and purchasing ingredient suppliers to lower long-term production costs; the company operates as a subsidiary of Xiaoqiu Holding Ltd.
Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization
Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization
Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America
Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy
Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.
Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering
Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
Why Is Park Ha Biological Technology Rocketing On Friday?
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group's wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH
Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering